<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Journal of Experimental and Clinical Surgery</journal-id><journal-title-group><journal-title xml:lang="en">Journal of Experimental and Clinical Surgery</journal-title><trans-title-group xml:lang="ru"><trans-title>Вестник экспериментальной и клинической хирургии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2070-478X</issn><issn publication-format="electronic">2409-143X</issn><publisher><publisher-name xml:lang="en">Voronezh State Medical University named after N.N. Burdenko</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">19</article-id><article-id pub-id-type="doi">10.18499/2070-478X-2013-6-1-9-18</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Original articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Оригинальные статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Unknown</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Changes of the Immune Status at Suffered from Burns, Including at Mass Accidents</article-title><trans-title-group xml:lang="ru"><trans-title>Изменения иммунного статуса у пострадавших от ожогов, в том числе при массовых катастрофах</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name><surname>Земсков</surname><given-names>В.M.</given-names></name><bio xml:lang="en"><p>Doctor of Medicine, Prof., honored Scientist of Russia, Recipient of the Prize of M.P Chumakov, head of the Group of Clinical Immunology, Institute of Surgery named after A.V. Vishnevsky</p></bio><bio xml:lang="ru"><p>д.м.н., проф., заслуженный деятель науки Российской Федерации, лауреат премии им. М.П.Чумакова, руководитель группы клинической иммунологии Института хирургии им. А.В.Вишневского</p></bio><email>vishnevskogo@ixv.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Алексеев</surname><given-names>А.А.</given-names></name><bio xml:lang="en"><p>Doctor of Medicine, Prof., Laureate of the State Prize of the Russian Federation, the Institute of Surgery named after A.V. Vishnevsky</p></bio><bio xml:lang="ru"><p>д.м.н, проф., лауреат Государственной премии Российской Федерации, сотрудник Института хирургии им. А.В.Вишневского</p></bio><email>author@vestnik-surgery.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Крутиков</surname><given-names>M.Г.</given-names></name><bio xml:lang="en"><p>Doctor of Medicine, Staff Member of the Institute of Surgery named after A.V. Vishnevsky</p></bio><bio xml:lang="ru"><p>д.м.н., сотрудник Института хирургии им. А.В.Вишневского</p></bio><email>author@vestnik-surgery.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Лагвилава</surname><given-names>M.Г.</given-names></name><bio xml:lang="en"><p>Doctor of Medicine, Staff Member of the Institute of Surgery named after A.V. Vishnevsky</p></bio><bio xml:lang="ru"><p>д.м.н., сотрудник Института хирургии им. А.В.Вишневского</p></bio><email>author@vestnik-surgery.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Козлова</surname><given-names>M.Н.</given-names></name><bio xml:lang="en"><p>Candidate of Medicine, Senior Researcher of the Group of Clinical Immunology, Institute of Surgery named after A.V. Vishnevsky</p></bio><bio xml:lang="ru"><p>к.м.н., старший научный сотрудник группы клинической иммунологии Института хирургии им. А. В. Вишневского</p></bio><email>author@vestnik-surgery.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Барсуков</surname><given-names>А.А.</given-names></name><bio xml:lang="en"><p>Candidate of Medicine, Senior Researcher of the Group of Clinical Immunology, Institute of Surgery named after A.V. Vishnevsky</p></bio><bio xml:lang="ru"><p>к.м.н., старший научный сотрудник группы клинической иммунологии Института хирургии им. А. В. Вишневского</p></bio><email>author@vestnik-surgery.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Соловьева</surname><given-names>M.С.</given-names></name><bio xml:lang="en"><p>Candidate of Medicine, Senior Researcher of the Group of Clinical Immunology, Institute of Surgery named after A.V. Vishnevsky</p></bio><bio xml:lang="ru"><p>к.м.н., старший научный сотрудник группы клинической иммунологии Института хирургии им. А. В. Вишневского</p></bio><email>author@vestnik-surgery.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Ахмадов</surname><given-names>M.A.</given-names></name><bio xml:lang="en"><p>Intramural Postgraduate Student of the Institute of Surgery named after A.V. Vishnevsky</p></bio><bio xml:lang="ru"><p>очный аспирант Института хирургии им. А.В.Вишневского</p></bio><email>author@vestnik-surgery.com</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Institute of Surgery Vishnevsky, Moscow, Russian Federation</institution></aff><aff><institution xml:lang="ru">Институт хирургии им. А.В.Вишневского, Москва, Российская Федерация</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2013-03-24" publication-format="electronic"><day>24</day><month>03</month><year>2013</year></pub-date><volume>6</volume><issue>1</issue><issue-title xml:lang="ru"/><fpage>9</fpage><lpage>18</lpage><history><date date-type="received" iso-8601-date="2016-04-24"><day>24</day><month>04</month><year>2016</year></date><date date-type="accepted" iso-8601-date="2016-04-24"><day>24</day><month>04</month><year>2016</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2013, Voronezh N.N. Burdenko State Medical University</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2013, ФГБОУ ВО ВГМУ им. Н.Н. Бурденко Минздрава России</copyright-statement><copyright-year>2013</copyright-year><copyright-holder xml:lang="en">Voronezh N.N. Burdenko State Medical University</copyright-holder><copyright-holder xml:lang="ru">ФГБОУ ВО ВГМУ им. Н.Н. Бурденко Минздрава России</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://vestnik-surgery.com/journal/about/editorialPolicies</ali:license_ref></license></permissions><self-uri xlink:href="https://vestnik-surgery.com/journal/article/view/19">https://vestnik-surgery.com/journal/article/view/19</self-uri><abstract xml:lang="en"><p><bold>Relevance</bold> Burn injury is one of the most severe types of traumatism. In this regard, infectious complications of burn disease are significantly more likely to develop, even in patients with relatively small area burns, and mortality rate increases substantially.</p><p><bold>The purpose of the study</bold> To detect changes in the amount of functional activity and to determine the prognostic significance of immune cells.</p><p><bold> Materials and methods</bold> The study was conducted on 38 patients at different periods of burn disease, depending on the area of   the burn injury and its depth, in the Burn Center of the Institute of Surgery named after A.V. Vishnevsky and the City Burn Center at the 36th City Clinical Hospital. Phenotypic analysis of lymphocytes, granulocytes and monocytes (constitutive and activation markers, the functional activity of cells) was performed.</p><p><bold>Results and their discussion</bold> In the period of acute burn toxemia in patients, significant changes in many immune parameters remain and are quite serious in 10-14 days after burn injury. In this regard, two cocurrent alternative processes are generally develop - hyperactivation of the immune system (leukocytosis with a shift of the blood count to the left, a sharp increase of granulocytes expressing the receptor of LPS and a high affinity Fcγ-receptor, increase of their oxygen metabolism, the functional activation of HLA-DR + monocytes) and its deep deficit (natural killer cells, lymphocytes, cytotoxic CD8 + T-cells, T-helpers and overall T-lymphocytes, B-lymphocytes).</p><p><bold>Conclusion</bold> Based on the analysis of the complex immune parameters, it is possible not only to predict the course and outcome of burn disease, but also to determine the necessary treatment in patients with severe burns, immunotherapy and evaluate its effectiveness.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Актуальность</bold> Ожоговая травма является одним из наиболее тяжелых видов травматизма, при этом значительно чаще развиваются инфекционные осложнения ожоговой болезни, даже у больных с относительно небольшими по площади ожогами, и существенно возрастает летальность.</p><p><bold> Цель исследования</bold> Выявление изменений в количестве, функциональной активности и определение прогностической значимости иммунокомпетентных клеток.</p><p><bold> Материалы и методы</bold> Исследования были проведены в ожоговом центре Института хирургии им. А.В.Вишневского и в городском ожоговом центре на базе 36-й ГКБ на 38 пациентах, в разные периоды ожоговой болезни, в зависимости от площади ожогового поражения и его глубины. Выполняли фенотипический анализ лимфоцитов, гранулоцитов и моноцитов (конститутивные и активационные маркеры, функциональная активность клеток).</p><p><bold> Результаты и их обсуждение</bold> В период острой ожоговой токсемии у обожженных сохраняются существенные изменения многих иммунных параметров и через 10-14 дней после ожоговой травмы сохраняются достаточно серьёзные изменения иммунной системы. При этом в основном развиваются два параллельно идущих альтернативных процесса – гиперактивация иммунной системы (лейкоцитоз со сдвигом формулы крови влево, резкое возрастание гранулоцитов с экспрессией рецептора ЛПС и высокоаффинного Fcγ-рецептора, усиление их кислородного метаболизма, функциональная активация HLA-DR+ моноцитов) и её глубокий дефицит (естественные киллеры, лимфоциты, цитотоксические CD8+ Т-лимфоциты, Т-хелперы и общие Т-лимфоциты, В-лимфоциты).</p><p><bold>Выводы</bold> На основании анализа комплекса иммунных показателей возможно не только прогнозировать течение и исход ожоговой болезни, но и определять необходимую в комплексоном лечении тяжелообоженных иммунотерапию и оценивать её эффективность.</p></trans-abstract><kwd-group xml:lang="en"><kwd>immune status</kwd><kwd>burns</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>иммунный статус</kwd><kwd>ожоги</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>1. Alekseev A.A. Ozhogovyi sepsis: diagnostika, profilaktika, lechenie. Diss. dokt. med. nauk [Burn sepsis: diagnosis, prevention and treatment. Med. sci. doct. diss.]. Moscow, 1993. 233 p.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>2. Belotskii S.M., Snastina T.I., Filiukova O.B. Mikrobnyj faktor v hemilyuminescenciya nejtrofilov v perifericheskoj krovi u bol'nyh s gnojnoj hirurgicheskoj infekciej. [Microbial factor in the chemiluminescence of neutrophils in peripheral blood of the patients with purulent surgical infection.] Zhurnal mikrobiologii, epidemiologii i immunologii, 1988; 8: 87-90.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>3. Zemskov A.M. , Zemskov V.M., Korotkikh I.N. e.a. Immunnye rasstroistva i ikh korrektsiia pri gnoino-vospalitel'nykh protsessakh [Immune disorders and their correction in chronic inflammatory processes]. Moscow, Triada-Kh., 2007. 159 p.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>4. Karelin A.A., Alekseev A.A., Globa A.G. e.a Fermentacionnoe proizvodstvo superoksid polimorfnoyadernymi lejkocitami u pacientov s ozhogovoj bolezn'yu. [Enzymatic production of superoxide by polymorphonuclear leukocytes in patients with burn disease.] Voprosy meditsinskoi khimii, 1988; 5: 107-110.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>5. Kolker I.I. Aktual'nye voprosy "infekciya i immunitet pri termicheskih travm" [Topical issues of "Infection and immunity in thermal injuries"]. Aktual'nye voprosy Khirurgii. Sbornik nauchnykh trudov Instituta khirurgii imeni A.V. Vishnevskogo AMN SSSR [Proc. of the Institution of Surgery named after Vishnevskii A.V. "Topical Issues of Surgery"]. Moscow, 1985, pp. 144-149.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>6. Kolker I.I. Immunologicheskie aspekty ozhogovoj bolezni [Immunological aspects of burn disease]. Tez. dokl. 3-i vsesoiuzn. konf. po probleme «Sovremennye sredstva pervoi pomoshchi i metody lecheniia ozhogovoi bolezni [Abstracts 3rd Conference "Modern first aid and treatment of burn disease"]. Moscow, 1986, pp. 191-193.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>7. Krutikov M.G. Infektsiia u obozhzhennykh: etiologiia, patogenez, diagnostika, profilaktika i lechenie. Diss.dokt. med. nauk [Infection in burn people: etiology, pathogenesis, diagnosis, prevention and treatment. Med. sci. doct. diss.]. Moscow, 2005, 371 p.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>8. Lukoianova T.N. Kliniko-immunologicheskie kriterii obosnovaniia i otsenki effektivnosti immunnokorregiruiushchei terapii u bol'nykh ozhogovoi bolezn'iu. Dis. kand. med. nauk [Clinical and immunological criteria for study and evaluation of the effectiveness of the immunnocorrective therapy in patients with burn disease. Med. sci. cand. diss.]. Moscow, 1990, 121 p.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>9. Pivovarova L.P., Ariskina O.B., Assur M.V. e.a. Immunologicheskij status i ego korrekciya u bol'nyh s ozhogovym sepsisom [Immunological status and its correction in patients with burn sepsis]. XIX s"ezd khirurgov Ukrainy. Sbornik nauchnykh trudov. [Proc. 19th Ukraine surgical congress] Khar'kov, 2000, pp. 337-338.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>10. Sergel' O.S., Morozov S.S. K voprosu o smysle mestnye ispytanij kletochnoj giperchuvstvitel'nosti pri ozhogovoj bolezni. [On the question of the meaning of local cellular hypersensitivity tests in burn disease.] 3-ia Vsesoiuznaia konferentsiia po probleme «Sovremennye sredstva pervoi pomoshchi i metody lecheniia ozhogovoi bolezni». Tezisy dokladov [Proc. 3rd Union Conference "Modern first aid and treatment methods of burn disease"]. Moscow, 1986, pp. 204-206.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>11. Fedorov V.D., Rivkin V.L., Gurseva Kh.F., Martynova T.N. Sovremennye vzglyady na techenie ranevogo processa i lecheniya ran. [Modern views on the course of wound healing and the treatment of wounds.] Khirurgiia, 1975, 4: 136-141. – (In Russian).</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>12. Diem E. Infekcii pri ozhogah. [Infections in burns.] 7th European congress of clinical microbiology and infectious diseases: Abstr.. Vienna, Austria. 1995; 15.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>13. Pruitt B.A., Polk h.C. Ozhogi i myagkih tkanej. [Burns and soft tissues.] Infection and the surgical patient, Churchill Livingstone. 1982; 4: 113-131. Received 18.05.2012</mixed-citation></ref></ref-list></back></article>
